The International Society of Gastrointestinal Oncology Selected Proceedings and Abstracts From the Eleventh Annual Conference.
Bibliographic record
Abstract
Selected proceedings and abstracts from the Eleventh Annual Conference of the International Society of Gastrointestinal Oncology (ISGIO) are contained in this supplement to Gastrointestinal Cancer Research. These papers and abstracts provide balanced information on current research and clinical care topics for a variety of GI tumor types, many of which are growing in incidence worldwide. The substantial anticipated burden of these malignancies underscores the importance of ISGIO's annual conference, where experts in multiple disciplines in the gastrointestinal (GI) oncology arena present their views to scientists, physicians, physician's assistants, and nurses from around the world. In addition to presentations that cover the current thinking and controversies in the field, the conference format includes interactive discussions and patient cases where participants can debate key issues and the available treatment options for patients during their clinical course. The opportunity to forge relationships for future partnerships in national and international GI oncology research efforts is another important benefit of attending this conference, and one that will ultimately help us provide better care for our patients. Attendees at the Eleventh Annual Conference, which was held October 23–24, 2014, in Arlington, Virginia, came from Canada, China, Greece, India, Israel, Italy, Japan, Spain, the United Kingdom, and the United States, reflecting the wide reach of the Society as well as the Society's goal to foster global communication among the scientific and medical communities. Papers and abstracts in this issue cover the epidemiology and biology of esophageal cancer, a disease with an alarming recent increase in incidence; radiation techniques used for esophageal and gastroesophageal cancer; chemoradiation as a component of treatment for patients with localized gastric or esophageal cancer; novel therapies under development for colorectal cancer; lymph node counts and survival rates after resection for colon or rectal cancer; current approaches and new directions in therapy for pancreatic cancer; and the development of gene signatures and molecular targets. These papers reflect some of the progress that has been made in GI oncology as well as the many questions and challenges that remain. I encourage you to attend the Twelfth Annual Meeting of the ISGIO, October 22–23, 2015, in Arlington, Virginia, to hear updates and new information that may be relevant to your practice. Visit www.ISGIO.org for registration and more information about the Society and the conference.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.005 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.002 | 0.002 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.004 | 0.002 |
| Open science | 0.001 | 0.002 |
| Research integrity | 0.002 | 0.003 |
| Insufficient payload (model declined to judge) | 0.245 | 0.161 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".